Calreticulin accelerates corneal wound closure and mitigates fibrosis: Potential therapeutic applications.

Authors:
Mishra S; Manzanares MA; Prater J; Culp D; Gold LI.

Journal:
J Cell Mol Med

Publication Year: 2023

DOI:
10.1111/jcmm.18027

PMCID:
PMC10902309

PMID:
37985392

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Cell Mol Med

Abbreviation: J Cell Mol Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adenine base editor-based correction of the cardiac pathogenic Lmna c.1621C > T mutation in murine …
Yang L; Liu Z; Sun J and 3 more (2024) - Transparency Score: 4/6
A systematic review on deep learning-based automated cancer diagnosis models.
Tandon R; Agrawal S; Rathore NPS and 2 more (2024) - Transparency Score: 3/6
Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H and 2 more (2024) - Transparency Score: 4/6
Construction of endothelial cell signatures for predicting the diagnosis, prognosis and immunothera…
Fu Y; Sun S; Shi D and 1 more (2024) - Transparency Score: 4/6
C-X-C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through β-caten…
Wu Q; Chen Q; Xu D and 12 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no competing interests."

Evidence found in paper:

"FUNDING INFORMATION Tissue Regeneration Sciences, Inc."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025